• Abbott, of Abbott Park, Ill., said the European Commission approved Humira (adalimumab) in moderately active Crohn's disease (CD) in adult patients who have not adequately responded to conventional therapy. The drug was previously approved in the European Union for severely active CD in adults.

The FDA approved Afinitor Disperz (everolimus tablets for oral suspension) by Novartis AG, of Basel, Switzerland, a pediatric dosage form of the anticancer drug Afinitor (everolimus, Novartis AG) in the rare brain tumor subependymal giant cell astrocytoma. The drug is the first approved pediatric-specific dosage form developed for the treatment of a pediatric tumor.